FDA DEVICE FACTS
Powder Free Nitrile Examination Gloves (Blue), Tested for Use with Chemotherapy Drugs
Shanxi Hongjin Plastic Technology Co., Ltd.
FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。
Indications for use
Powder Free Nitrile Examination Gloves (Blue), Tested for Use with Chemotherapy Drugs is a disposable device intended for medical purposes that is worn on the examiner's hand to prevent contamination between patient and examiner. Gloves have been tested for use with chemotherapy drugs using ASTM D6978 and will be labeled with a statement of compliance and a summary of the testing results. Chemotherapy Drug Permeation The following chemicals have been tested with these gloves: * Please note that the following drugs have extremely low permeation times: Chemotherapy Drug Bleomycin (15.0mg/ml) Bortezomib (Velcade) lmg/ml Busulfan (6.0mg/ml) Carboplatin, (10.0mg/ml) Carmustine(BCNU) (3.3 mg/ml) Chloroquine, (50.0mg/ml) Cisplatin (lmg/ml) Cyclophosphamide (Cytoxan) (20mg/ml) Cyclosporin, (100.Omg/ml) Cytarabine, (100.0mg/ml) Dacarbazine (10mg/ml) Daunorubicin, HCL (5.Omg/ml) Docetaxel, (10.Omg/ml) Doxorubicin HCL (2mg/ml) Epirubicin HCL (Ellence), (2.0mg/ml) Etoposide (20mg/ml) Fludarabine, (25.0mg/ml) Fluorouracil (50mg/ml) Gemcitabine (38.0mg/ml) Idarubicin HCL (1.0mg/ml) Ifosfamide, (50.Omg/ml) Irinotecan, (20.0mg/ml) Mechlorethamine HCI, (1.0mg/ml) Melphalan, (5.0mg/ml) Methotrexate (25mg/ml) Mitomycin C, (0.5mg/ml) Mitoxantrone, (2.0mg/ml) Oxaliplatin, (5.Omg/ml) Paclitaxel (Taxol) (6mg/ml) Paraplatin, (10.0mg/ml) Retrovir, (10.0mg/ml) Rituximab, (10.0mg/ml) Thio Tepa (10mg/ml) Topotecan HCL, (1.0mg/ml) Minimum BDT (Minutes) >240 >240 >240 >240 7.0 >240 >240 >240 >240 >240 >240 >240 >240 >240 >240 >240 >240 >240 >240 >240 >240 >240 >240 >240 >240 >240 >240 >240 >240 >240 >240 >240 23.0 >240 Trisonex, (1.0mg/ml) Vincristine, (1.0mg/ml) >240 >240 Please note that the following drugs have extremely low permeation times: Carmustine (BCNU): 7.0 minutes, Thio Tepa: 23 minutes, Warning: Do not use with Carmustine (BCNU) and Thio Tepa.
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。